Organic vegetables

Into the mainstream: the evolving organics sector in France

With EUR 8bn of sales, the organic sector is become especially well-established in France as the trend towards ‘naturalness’ in products continues. This new report explores whether generalist retailers may dominate this fast-evolving sector in France.

Click here to download the report >>


Healthcare market update - September 2019

The healthcare sector shrugged off summer breaks and market volatility with a packed schedule of new fund launches, private placement activity and deal flow.

Click here to download the report >>


Advancing the future of healthcare

From early-stage finance to IPO and beyond, we help the healthcare innovators of today become the leaders of tomorrow. With over 20 years of experience our team of expert investment bankers, equity research analysts and institutional sales people cover the market's key sub-sectors.

So, whether you are a biotechnology company, large cap pharmaceutical, specialty pharma, developer of life science tools, medical technology, work in diagnostics, healthcare IT or in healthcare services, we can help you grow your business.

Read our healthcare brochure to find out how >>


Healthcare market update - July 2019

In this month's market round up: US and European healthcare IPO activity returned to growth in a month that also saw significant M&A activity, including moves that further underline the sector’s digitisation.

Click here to download the report >>


Edge computing

As artificial intelligence and IOT devices spread into industries such as automotive and healthcare, cloud architectures cannot to provide the latency, security and privacy needed. This is driving growth in ‘edge computing’, which looks set to benefit a broader range of players than cloud: from start-ups to well-established microcontroller firms and outsourced embedded computing companies.

Click here to download the report >>


Healthcare market update - June 2019

This months’ Healthcare Market Update rounds up what was a busy month for raises in particular, as several biotechs announced Nasdaq IPO plans.

Click here to download the report >>


Healthcare market update - May 2019

In this Healthcare Market Update we look at the state of biotech financing in the US and highight the month’s major developments and transactions.

Click here to download the report >>


Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance

Bryan, Garnier & Co combines with Nordic growth investment bank Beringer Finance, further strengthening the firm’s leadership in the European investment banking landscape.

  • The group expands its European footprint with the addition of offices in Stockholm, Oslo and Reykjavik. Bryan, Garnier & Co will also add the current Beringer Finance Palo Alto office to its existing US presence in NYC.
  • CEO Adalsteinn Johannsson will join Bryan, Garnier & Co as Partner focused on International M&A, with Beringer’s Tor Berthelius as Partner to lead the Nordic operations.
  • The combination reinforces the group with 31 professionals focused on Technology, IT Services and Fintech.
  • Beringer has conducted more than 140 M&A, ECM and Private Placements transactions in the past 10 years alone, and benefits from a leading position in the Nordic markets.
  • The combination provides a strong foothold for the firm to expand its leading European Life-Sciences practice in the Nordics.

[London, Paris, Munich] — Wednesday 17th April, 2019. Today, Bryan, Garnier & Co announced the acquisition of Beringer Finance and the expansion of its partnership. Beringer Finance is a premier, Nordic-focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Throughout the past 10 years, Beringer Finance has advised on over 140 transactions, building a strong track record in the TMT, IT Services, and Fintech markets. The closing is subject to pending regulatory approvals and other customary closing conditions.

Olivier Garnier, Co-founder and Managing Partner of Bryan, Garnier & Co comments: “Bryan, Garnier & Co is an independent partnership that combines highly experienced, entrepreneur-minded investment banking professionals with the services and expertise of a top-tier investment bank. The culture of excellence at Beringer Finance and our shared ambition to expand will be a strong driver to accelerate Bryan, Garnier & Co’s development in the region, across our business lines and industry sectors. We are delighted to welcome Adalsteinn Johannsson and his team to lead this effort”.

“The Nordics is one of the main European Technology and Life Sciences hubs where we have longstanding client relationships” comments Greg Revenu, Managing Partner of Bryan, Garnier & Co. “This combination not only creates an exciting opportunity for the firm and its teams, but also a unique capacity to support the growth of our clients: it propels our Technology coverage to the next level, while opening a new challenge to our leading European healthcare franchise.”

“We are excited to be joining forces with Bryan, Garnier & Co” explains Adalsteinn Johannsson, CEO at Beringer Finance. “Its full-service capacities combining investment banking and capital markets services provides us with the scale and resources to accelerate our growth. Bryan, Garnier & Co’s entrepreneurial DNA is a perfect match for the strong culture and unique approach we have built at Beringer. We very much look forward writing this journey together with this outstanding team.”

Beringer Finance will be operating under the Bryan, Garnier & Co brand with CEO Adalsteinn Johannsson joining Bryan, Garnier & Co as a partner focused on International M&A, with Beringer’s Tor Berthelius as a partner to lead the Nordic operations. Beringer’s 27 technology-focused bankers will be fully integrated with Bryan, Garnier & Co’s existing investment banking professionals, across its London, Paris, Munich, Stockholm, Oslo, Reykjavik, New York and Palo Alto offices. With a European technology group of more than 80 professionals, Bryan, Garnier & Co will benefit from an unmatched position in the European technology investment banking landscape.

RECENT ACHIEVEMENTS

Over the past 24 months, Bryan, Garnier & Co and Beringer Finance have led more than 85 transactions, including backing three of the most disruptive unicorns of 2018:

  • 47 international public and private M&A deals representing an aggregate value of approximately $2.4 billion, many of which involved tier one private equity investors and publicly-listed trade buyers. Recent deals include the sale of Sword Apak to Sopra Banking Software, the sale of Symetis to Boston Scientific for $435m, the sale of Dimelo to RingCentral, the sale of Prima Solutions to the Carlyle Group, the 30% sale of Advania to VIA equity and PFA, and the sale of Universum to Axel Springer company StepStone.
  • 25 growth capital private placements and PIPEs representing an aggregated amount raised of some $550 million, for companies such as blockchain unicorn Bitfury ($80m), biotech unicorn Moderna ($80m), Tado° ($50m), Highlife ($37m), Devialet ($210m), and BraBank ($35m).
  • 15 IPOs and public offerings on Nasdaq, NYSE, Euronext, and other major exchanges for an aggregated amount of more than $1.4 billion, including four deals led or co-led on Nasdaq or NYSE. Recent transactions include: representation of cannabis unicorn Canopy Growth ($450m, TMX, NYSE), Medartis ($138m, Swiss Exchange), Materialise ($52m, Nasdaq), Medigene ($56m, Deutsche Börse Group), Celyad ($53m, Nasdaq, Euronext) and Genfit ($155.4m, Nasdaq).

About Beringer Finance

Beringer Finance is a technology focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Tracing its roots back over 100 years, Beringer is continuously driven by the ambition to help companies and entrepreneurs strategically develop and grow their businesses while realizing their dreams and their aspirations.
Their expertise and market leadership have seen them advise top-tier clients on over 140 transactions in the past 10 years. Despite calling the Nordics its home, Beringer works across all continents and focuses on M&A and private placements after selling its Fondsfinans brokerage business in 2018.

(www.beringerfinance.com)

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorised and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.

(www.bryangarnier.com)


Healthcare market update - April 2019

Our latest Healthcare Market Update looks at changes in the FDA, M&A activity over the past month, pharma pipelines and new drug approvals.

Click here to download the report >>


The new big data world

The convergence of cloud computing, big data, IOT and artificial intelligence has transformed the database industry. Although relational databases still dominate, newer technologies such as Hadoop, NoSQL and NewsSQL are driving waves of acquisition and consolidation. While Oracle and Amazon fight over the #1 spot, there are also plenty of potential unicorns in the sector.

Click here to download the report >>